本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerie Pharmaceuticals Inc.

15.25
0.0000
成交量:- -
成交额:1,853.09万
市值:7.54亿
市盈率:-19.77
高:15.25
开:15.25
低:15.25
收:15.25
52周最高:15.37
52周最低:4.81
股本:4,941.74万
流通股本:4,374.79万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.7712
每股收益(LYR):-1.6145
净资产收益率:-2255.01%
总资产收益率:-4.59%
市净率:-4.60
市盈率(LYR):-9.45

数据加载中...

2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/21

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/11/21

重要事件披露

8-K - Current report
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/21

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/11/18

重要事件披露

8-K - Current report
2022/11/07

重要事件披露

8-K - Current report
2022/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/09/13

重要事件披露

8-K - Current report
2022/08/23

重要事件披露

8-K - Current report
2022/08/23

重要事件披露

8-K - Current report
2022/08/05

重要事件披露

8-K - Current report
2022/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]